• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effects of extracorporeal membrane oxygenation on morphine pharmacokinetics in infants.

作者信息

Dagan O, Klein J, Bohn D, Koren G

机构信息

Department of Critical Care, Hospital for Sick Children, Toronto, ON, Canada.

出版信息

Crit Care Med. 1994 Jul;22(7):1099-101. doi: 10.1097/00003246-199407000-00008.

DOI:10.1097/00003246-199407000-00008
PMID:8026197
Abstract

OBJECTIVES

To study the effect of extracorporeal membrane oxygenation (ECMO) on the pharmacokinetics of morphine in infants.

DESIGN

A prospective, comparative study of morphine pharmacokinetics during and after ECMO.

SETTING

The pediatric intensive care unit at a children's hospital.

PATIENTS

Seven infants, aged 1 day to 12 months, requiring ECMO.

INTERVENTION

Infusion of morphine.

MEASUREMENT AND MAIN RESULTS

Steady-state concentrations of morphine were used to generate a morphine clearance rate. Plasma clearance rate of morphine increased from 0.574 +/- 0.3 L/kg/hr to 1.058 +/- 0.727 L/kg/hr after discontinuation of ECMO (p < .01). Two infants experienced a clinical picture consistent with opioid withdrawal.

CONCLUSION

Infants requiring morphine after ECMO may require higher dose rates to maintain adequate sedation.

摘要

相似文献

1
Effects of extracorporeal membrane oxygenation on morphine pharmacokinetics in infants.
Crit Care Med. 1994 Jul;22(7):1099-101. doi: 10.1097/00003246-199407000-00008.
2
Morphine pharmacokinetics during continuous infusion of morphine sulfate for infants receiving extracorporeal membrane oxygenation.
Crit Care Med. 1997 Feb;25(2):360-4. doi: 10.1097/00003246-199702000-00027.
3
Primary use of the venovenous approach for extracorporeal membrane oxygenation in pediatric acute respiratory failure.静脉-静脉途径在小儿急性呼吸衰竭体外膜肺氧合中的主要应用
Pediatr Crit Care Med. 2003 Jul;4(3):291-8. doi: 10.1097/01.PCC.0000074261.09027.E1.
4
Extracorporeal membrane oxygenation exposes infants to the plasticizer, di(2-ethylhexyl)phthalate.体外膜肺氧合使婴儿暴露于增塑剂邻苯二甲酸二(2-乙基己基)酯中。
Crit Care Med. 1997 Apr;25(4):696-703. doi: 10.1097/00003246-199704000-00023.
5
Morphine pharmacokinetics during venoarterial extracorporeal membrane oxygenation in neonates.新生儿静脉-动脉体外膜肺氧合期间吗啡的药代动力学
Intensive Care Med. 2005 Feb;31(2):257-63. doi: 10.1007/s00134-004-2545-5. Epub 2005 Jan 28.
6
Neonatal respiratory extracorporeal membrane oxygenation (ECMO) referrals.新生儿呼吸体外膜肺氧合(ECMO)转诊。
Ir Med J. 2011 Mar;104(3):78-81.
7
Morphine metabolite pharmacokinetics during venoarterial extra corporeal membrane oxygenation in neonates.新生儿静脉-动脉体外膜肺氧合期间吗啡代谢物的药代动力学
Clin Pharmacokinet. 2006;45(7):705-14. doi: 10.2165/00003088-200645070-00005.
8
The changing demographics of neonatal extracorporeal membrane oxygenation patients reported to the Extracorporeal Life Support Organization (ELSO) Registry.向体外生命支持组织(ELSO)登记处报告的新生儿体外膜肺氧合患者的人口统计学变化。
Pediatrics. 2000 Dec;106(6):1334-8. doi: 10.1542/peds.106.6.1334.
9
Sedation Management in Children Supported on Extracorporeal Membrane Oxygenation for Acute Respiratory Failure.急性呼吸衰竭患儿体外膜肺氧合支持下的镇静管理
Crit Care Med. 2017 Oct;45(10):e1001-e1010. doi: 10.1097/CCM.0000000000002540.
10
International experience with trisomy 21 infants placed on extracorporeal membrane oxygenation.对接受体外膜肺氧合治疗的21三体综合征婴儿的国际经验。
Pediatrics. 2001 Mar;107(3):549-52. doi: 10.1542/peds.107.3.549.

引用本文的文献

1
Impact of drug exposure on neonates requiring ECMO: A retrospective cohort study.药物暴露对需要体外膜肺氧合(ECMO)的新生儿的影响:一项回顾性队列研究。
Front Pediatr. 2023 Mar 27;11:1020716. doi: 10.3389/fped.2023.1020716. eCollection 2023.
2
Sedative and Analgesic Pharmacokinetics During Pediatric ECMO.小儿体外膜肺氧合期间的镇静和镇痛药物动力学
J Pediatr Pharmacol Ther. 2020;25(8):675-688. doi: 10.5863/1551-6776-25.8.675. Epub 2020 Nov 13.
3
Organ donation in patients on extracorporeal membrane oxygenation: considerations for determination of death and withdrawal of life support.
体外膜肺氧合患者的器官捐献:死亡判定及生命支持撤除的考量
Can J Anaesth. 2020 Aug;67(8):1035-1043. doi: 10.1007/s12630-020-01714-4. Epub 2020 May 21.
4
Extracorporeal Life Support: Four Decades and Counting.体外生命支持:四十年仍在继续。
Curr Anesthesiol Rep. 2017;7(2):168-182. doi: 10.1007/s40140-017-0210-0. Epub 2017 Apr 12.
5
Patterns of Medication Exposure in Children on Extracorporeal Membrane Oxygenation: A Step in Prioritizing Future Pharmacologic Studies.接受体外膜肺氧合治疗的儿童的药物暴露模式:迈向优先开展未来药理学研究的一步。
Crit Care Explor. 2019 Sep 16;1(9):e0045. doi: 10.1097/CCE.0000000000000045. eCollection 2019 Sep.
6
Drug Disposition and Pharmacotherapy in Neonatal ECMO: From Fragmented Data to Integrated Knowledge.新生儿体外膜肺氧合中的药物处置与药物治疗:从零散数据到综合知识
Front Pediatr. 2019 Sep 3;7:360. doi: 10.3389/fped.2019.00360. eCollection 2019.
7
Dexmedetomidine extraction by the extracorporeal membrane oxygenation circuit: results from an in vitro study.体外膜肺氧合回路中右美托咪定的提取:一项体外研究的结果。
Perfusion. 2020 Apr;35(3):209-216. doi: 10.1177/0267659119868062. Epub 2019 Aug 21.
8
Drugs pharmacokinetics during veno-venous extracorporeal membrane oxygenation in pediatrics.小儿静脉-静脉体外膜肺氧合期间药物的药代动力学
J Thorac Dis. 2018 Mar;10(Suppl 5):S642-S652. doi: 10.21037/jtd.2017.11.02.
9
Optimising drug dosing in patients receiving extracorporeal membrane oxygenation.优化接受体外膜肺氧合治疗患者的药物剂量
J Thorac Dis. 2018 Mar;10(Suppl 5):S629-S641. doi: 10.21037/jtd.2017.09.154.
10
Antifungal Extraction by the Extracorporeal Membrane Oxygenation Circuit.体外膜肺氧合回路的抗真菌提取
J Extra Corpor Technol. 2017 Sep;49(3):150-159.